David Mowry - Alphatec Holdings Independent Director

ATEC Stock  USD 13.80  0.39  2.91%   

Director

Mr. David H. Mowry is Independent Director of the Company. Mr. Mowry is President and Chief Executive Officer, as well as a member of the Board of Directors, of Vyaire Medical, a global leader in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments, a position he has held since May 2016. From October 2015 to May 2016 he served as Executive Vice President and Chief Operating Officer and member of the Board of Directors of Wright Medical Group N.V., a global medical device company focused on extremities and biologics products, and during this time period he was also a member of the Board of Directors of EndoChoice Holdings, Inc., a company focused on the manufacturing and commercialization of platform technologies relating to the treatment of gastrointestinal conditions. Prior to Wright Medical Group, Mr. Mowry served as President and Chief Executive Officer and member of the Board of Directors of Tornier N.V. from February 2013 until October 2015, at which time Tornier and Wright Medical Group merged, and prior to that, as Chief Operating Officer of Tornier from 2011 to 2013. Within the spine industry, Mr. Mowry served as Vice President of Operations and Logistics at Zimmer Spine from February 2002 until October 2006. Prior to this, Mr. Mowry held executive leadership positions at Covidien plc, ev3, Inc. and Zimmer Spine, Inc since 2017.
Age 55
Tenure 7 years
Address 1950 Camino Vida Roble, Carlsbad, CA, United States, 92008
Phone760 431 9286
Webhttps://www.atecspine.com
Mowry received a B.S. degree in Engineering from the United States Military Academy at West Point.

Alphatec Holdings Management Efficiency

The company has return on total asset (ROA) of (0.1398) % which means that it has lost $0.1398 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1175) %, meaning that it created substantial loss on money invested by shareholders. Alphatec Holdings' management efficiency ratios could be used to measure how well Alphatec Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of March 28, 2024, Return On Capital Employed is expected to decline to -0.24. In addition to that, Return On Assets is expected to decline to -0.24. At present, Alphatec Holdings' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 371.8 M, whereas Other Assets are forecasted to decline to 0.95.
The company currently holds 541.68 M in liabilities. Alphatec Holdings has a current ratio of 2.15, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Alphatec Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Alphatec Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alphatec Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alphatec to invest in growth at high rates of return. When we think about Alphatec Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Jeffrey DavisLaboratory
57
George KurianCigna Corp
54
Garheng KongLaboratory
45
Karey BarkerMednax Inc
52
Roman MartinezCigna Corp
71
Gary GillilandLaboratory
63
TimothyCigna Corp
N/A
Mark McClellanCigna Corp
57
William ZollarsCigna Corp
70
Aaref HilalyGuardant Health
46
Waldemar CarloMednax Inc
67
Peter NeupertLaboratory
65
Kimberly RossCigna Corp
56
James RogersCigna Corp
69
Sanders WilliamsLaboratory
69
Richelle ParhamLaboratory
53
John PartridgeCigna Corp
71
Bahija JallalGuardant Health
56
Paul GabosMednax Inc
55
Alfred LimEUDA Health Holdings
72
Pascal GoldschmidtMednax Inc
65
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company was founded in 1990 and is headquartered in Carlsbad, California. Alphatec Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 561 people. Alphatec Holdings (ATEC) is traded on NASDAQ Exchange in USA. It is located in 1950 Camino Vida Roble, Carlsbad, CA, United States, 92008 and employs 839 people. Alphatec Holdings is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Alphatec Holdings Leadership Team

Elected by the shareholders, the Alphatec Holdings' board of directors comprises two types of representatives: Alphatec Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alphatec. The board's role is to monitor Alphatec Holdings' management team and ensure that shareholders' interests are well served. Alphatec Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alphatec Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Black, CFO, Executive Vice President
John Foster, Director
David Mowry, Independent Director
Karen McGinnis, Independent Director
Ali Shorooghi, Senior Marketing
Jon Allen, Executive Vice President - Commercial Operations
Leslie Cross, Chairman of the Board
Rohit Desai, Independent Director
Stephen ONeil, Independent Director
Michael ONeill, CFO, Vice President Treasurer
Stephen Lubischer, VP of Sales
Michael Plunkett, COO
Tom Davis, Independent Director
Donald Williams, Independent Director
Mortimer Berkowitz, Director
Kristin Leary, Sr. VP of Global HR
Jeffrey Rydin, Director
Terry Rich, CEO, Director
Jonathan Allen, Executive Vice President - Commercial Operations
Quentin Blackford, Director
Siri Marshall, Independent Director
Christine Zedelmayer, IR Contact Officer
James Corbett, CEO and President Director and Member of Executive Committee
Dennis Nelson, Interim Principal Financial and Accounting Officer
Patrick Miles, Chairman of the Board
Lance Denardin, Vice President - West
Scott Lish, Vice President - Development
Brian Snider, Executive Vice President - Strategic Marketing and Product Development
Ebun Garner, Senior Vice President General Counsel, Secretary
James Tullis, Director
Amy Ables, Vice President - Corporate Education & Performance
lan Molson, Independent Director
Michael Dendinger, Vice President - Operations
Eric Dasso, Executive Technologies
Evan Bakst, Director
R Molson, Independent Director
Tyson Marshall, General Secretary
David Sponsel, Executive Vice President - Sales
Mitsuo Asai, President of Alphatec Pacific Inc
Kelli Howell, Executive Vice President - Clinical Strategies
Ward Woods, Independent Director
Luiz Pimenta, Chief Medical Officer
Craig Hunsaker, Executive Vice President - People and Culture
Todd Koning, Executive CFO
Jason Hochberg, Director
Mark Ojeda, Executive Vice President Cervical and Biologics

Alphatec Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alphatec Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Alphatec Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alphatec Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alphatec Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving together with Alphatec Stock

  0.79MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr

Moving against Alphatec Stock

  0.81FEMY Femasys Report 4th of April 2024 PairCorr
  0.73NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr
  0.73CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.41XTNT Xtant Medical HoldingsPairCorr
The ability to find closely correlated positions to Alphatec Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alphatec Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alphatec Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alphatec Holdings to buy it.
The correlation of Alphatec Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alphatec Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alphatec Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alphatec Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alphatec Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alphatec Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alphatec Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alphatec Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alphatec Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Alphatec Stock refer to our How to Trade Alphatec Stock guide.
Note that the Alphatec Holdings information on this page should be used as a complementary analysis to other Alphatec Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Alphatec Stock analysis

When running Alphatec Holdings' price analysis, check to measure Alphatec Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alphatec Holdings is operating at the current time. Most of Alphatec Holdings' value examination focuses on studying past and present price action to predict the probability of Alphatec Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alphatec Holdings' price. Additionally, you may evaluate how the addition of Alphatec Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Alphatec Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alphatec Holdings. If investors know Alphatec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alphatec Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
3.978
Quarterly Revenue Growth
0.302
Return On Assets
(0.14)
Return On Equity
(4.12)
The market value of Alphatec Holdings is measured differently than its book value, which is the value of Alphatec that is recorded on the company's balance sheet. Investors also form their own opinion of Alphatec Holdings' value that differs from its market value or its book value, called intrinsic value, which is Alphatec Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alphatec Holdings' market value can be influenced by many factors that don't directly affect Alphatec Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alphatec Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alphatec Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alphatec Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.